1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 30 MARCH 2015

World Generic Markets 30 MARCH 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Sun/Ranbaxy Merger Will Create New Global Generics Major
Industry Brief - Apotex Realigns Structure And Operating Model
Industry Brief - TWi Initiates First Shipments To US
Industry Brief - InSite Settles Azithromycin Litigation With Mylan
Industry Brief - Aurobindo Gains Lacosamide Tentative Approval
Industry Brief - Noven Files Oestradiol Patent Lawsuit Against Actavis
Industry Brief - Pfenex Collaboration With Hospira Gains Early HSR Clearance
Industry Trend Analysis - Alternative Labelling Change Proposal Will Close Legal Loophole
Industry Brief - Samsung Bioepis Submits Infliximab MAA To EMA
Industry Trend Analysis - STADA Tie-In With Hetero Will Boost Both Companies' Profiles
Industry Trend Analysis - Allergan Acquisition Will Put Actavis Head-To-Head With Teva
Industry Trend Analysis - Viable Generic Sofosbuvir Market Will Increase Pricing Pressures For Gilead
Industry Brief - Consilient Launches Pregabalin Capsules In UK
Industry Trend Analysis - Gilead's Anti-Diversion Plans Will Increase Criticism
Industry Brief - Lupin Acquires Pharma Dynamics

Table Of Contents

World Generic Markets 30 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.